Skip to main content
Premium Trial:

Request an Annual Quote

Radboud UMC, NimaGen Partner to Develop Targeted Sequencing Kits

NEW YORK (GenomeWeb) – Radboud University Medical Center and NimaGen said today that they have agreed to codevelop target enrichment library prep kits for next-generation sequencing.

Specifically, the partners plan to develop kits based on single-molecule molecular inversion probes (smMIPs). NimaGen will manufacture the kits to be sold under its proprietary EasySeq technology line. Alexander Hoischen, an assistant professor at Radboud UMC, said in a statement that smMIPs have "key advantages, including ease of use and high accuracy."

The agreement builds on a previous collaboration under which Radboud and NimaGen codeveloped an oncology hotspot kit and a kit to analyze the BRCA1 and BRCA2 genes. NimaGen also manufactures and sells those kits under its EasySeq line.

The new collaboration "will enable us to integrate the expertise of Radboud UMC into NimaGen's growing portfolio of NGS products," NimaGen CEO Ruud van der Steen added.

The partners also noted that they are now developing a pharmacogenomics panel and a Lynch syndrome panel. 

The Scan

University of Michigan President Fired

Mark Schlissel, the president of the University of Michigan, has been fired after an investigation into allegations he had an affair with a subordinate, the Washington Post reports.

Recommendation to Drop Charges

The Wall Street Journal says federal prosecutors recommended charges against MIT's Gang Chen, who was caught up by the China Initiative, be dropped.

Mix 'Em Together

The Guardian reports Moderna is planning to have a combination SARS-CoV-2, influenza, and RSV vaccine by the 2023 flu season.

PNAS Papers on Earth BioGenome Project, SETX Knockouts, Pig Model of Cystic Fibrosis

In PNAS this week: Earth BioGenome Project reports progress, analysis of cells missing the progressive neurodegenerative disease-linked SETX gene, and more.